I have been involved in launching medtech products across nearly 30 markets. These are the lessons that only became clear ...
It’s been over 18 months since I last covered Lightwave Logic and the company still has no revenues despite a commercial agreement in May 2023. I’m pessimistic about the commercialization of the ...
Hosted on MSN
Hyliion lowers 2025 revenue outlook to $5M-$10M as commercialization shifts to 2026, supported by 30% tax credit
Healy confirmed, "we continue to expect that we will deliver all 10 Early Adopter units in 2025. Based on our current development and build schedule, we now expect that additional KARNO unit ...
1don MSN
Ideal Power outlines $10.5M cash burn target for 2026 while accelerating B-TRAN commercialization
Q4 2025 Management View CEO David Somo highlighted a multiyear strategic cooperation agreement with Lazzen for the design, development, and global sales of B-TRAN-enabled circuit protection products, ...
Through a curated team of the world’s most experienced and qualified dieticians, performance coaches, scientists, and medical professionals who are subject matter experts in their respective fields, ...
On July 26, 2022, the Energy Regulatory Commission (“CRE”) published a preliminary draft of new “General Administrative Provisions that establish the requirements for the filing of applications, ...
BOSTON--(BUSINESS WIRE)--Micropep Technologies (Micropep), a global leader in micropeptide technology, today announced the appointment of Alexandre Frateschi as its new chief business officer. He is a ...
Having a strong company culture is a competitive advantage that drives the ability to attract top talent and foster innovation. In many biotechs' early stages, they cultivate a research-focused ...
Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer Biomet. "We plan on providing financial guidance for fiscal year 2026 once we ...
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market.
Stereotaxis, Inc. announced it has secured approximately $12.5 million through a registered direct stock offering priced at $2.00 per share, led by a strategic industry partner and select ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results